Global Pigmented Lesion Treatment Market Is Expanding Owing To Growing Demand For Fast Recovery Treatment Procedures And Rising Adoption Of Synthetic Cosmetic Products

 

Pigmented Lesion Treatment Market

Overview:

Pigmented lesion treatment is a safe, non-invasive and effective treatment for the removal of unwanted pigmented lesions, including sun spots, age spots and freckles. This treatment is performed on the face and hands to help restore a more youthful appearance. A short pulse of light is used to safely and effectively remove brown pigmented lesions, creating a smooth, flawless complexion. The energy released by the light device is readily absorbed by excess melanin in the skin and destroys melanin-rich cells while preserving the surrounding skin tissue. During the treatment, a protective eye cover is provided, once the applicator is in place, a short pulse of light is released and quickly absorbed by excess melanin in the targeted area. Microdermabrasion and chemical peels to treat minimal and superficial discoloration. They are safe, effective and can be tailored to a specific patient's needs. For more serious types of hyperpigmentation, such as those due to acne or age spots, a daily retinoid moisturizer is recommended. This will help banish discoloration and prevent it from resurfacing in the future.

Market Dynamics:

Growing technological advancements are estimated to augment growth of the global pigmented lesion treatment market over the forecast period. For instance, in March 2023, a medical technology company STRATA Skin Sciences, Inc., declared the launch of the new XTRAC^® website. This new website will educates patients regarding XTRAC excimer laser therapy for treating vitiligo, atopic dermatitis, and psoriasis. Moreover, increasing side effects associated with laser treatment is expected to restrain growth of the global pigmented lesion treatment market over the forecast period.

Impact of COVID-19:

COVID-19 had a significant impact on many countries globally. It was first identified in China and from there it spread to other nations like India, Spain, Italy, France, UAE, Australia and many more. All these nations had to impose strict measures for preventing the spread of the virus. Several individuals lost their lives owing to this outbreak. The pandemic had a huge impact on the healthcare sector. All hospitals were running on full capacity, there was a shortage of drugs, medical equipment and other essential items. There was huge demand for skilled healthcare professionals across the globe. Many hospitals were prioritizing COVID-19 patients over other patients and this had a negative impact on the growth of the global pigmented lesion treatment market.

Key Takeaways:

 

The global pigmented lesion treatment market is expected to witness robust  growth, exhibiting CAGR of 7.7 % during the forecast period, due to growing adoption of inorganic growth strategies by key players. For instance, Bausch Health Cos Inc., is planning to pursue an initial public offering of their medical aesthetics business Solta Medical, in August 2021.

 

North America is anticipated to witness significant growth in the global pigmented lesion treatment market during the forecast period, owing to rising prevalence of pigmentation disorders and growing presence of well-established healthcare infrastructure.

 

Key players active in the global pigmented lesion treatment market are Syneron Medical Ltd., Alma Lasers Ltd., Strata Skin Sciences Inc., Cutera Inc., Solta Medical Inc., Lumenis Ltd., Lynton Lasers Ltd, and Lutronic Corporation.